This leaflet answers some common questions about DBL Cisplatin Injection. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

INT230-6 combines cisplatin, vinblastine, and a penetration enhancer for intratumor injection, aiming to engage the immune system without immunosuppression. The INVINCIBLE-4 trial compares INT230-6 ...

SEC recommends approval of additional indication for BMS' anti-cancer drug nivolumab: Gireesh Babu, New Delhi Tuesday, November 19, 2024, 08:00 Hrs [IST] The Subject Expert Commit ...